Tideglusib
PHRI.TaRGET
Phase 2 small_molecule active
Quick answer
Tideglusib for Arrhythmogenic Cardiomyopathy is a Phase 2 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RHYTHM PHARMACEUTICALS, INC.
- Indication
- Arrhythmogenic Cardiomyopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active